a placebo-controlled , double-blind crossover study was carried out in 11 non-insulin-dependent ( type 2 ) diabetic patients to find out the effects of a hepatic enzyme inducer ( phenobarbital , 100 mg/day for 2 months ) on the metabolic control , plasma c-peptide , insulin , serum , and lipoprotein lipid levels .
C0032105
plasma
C0229671
serum